Shao Zhimin
✓Chief Physician, Professor, Doctoral Supervisor; Director of the Department of Breast Surgery; Director of the Fudan University Cancer Research Instit
Chairman of the 5th and 6th Committees of the Breast Cancer Professional Committee, China Anti-Cancer Association (2005–2012); Former Chairman of the Targeted Cancer Therapy Professional Committee, China Anti-Cancer Association; Council Member of the Chinese Society of Clinical Oncology (CSCO); Former Vice-Chairman of the Oncology Branch, Chinese Medical Association and Honorary Leader of its Breast Oncology Group; Leader of the Breast Cancer Working Group under the Clinical Precision Medicine Professional Committee, Chinese Medical Doctor Association; Vice President of the Shanghai Anti-Cancer Association; Honorary Chairman of the Breast Cancer Professional Committee, Shanghai Anti-Cancer Association; Honorary Chairman of the Oncology Specialty Branch, Shanghai Medical Association; Chairman of the 8th Asian Breast Cancer Association; Member of the International Expert Panel for the St. Gallen Breast Cancer Conference, Europe.
The team successfully increased the 5-year survival rate for newly diagnosed breast cancer patients from 79.8% two decades ago to 93.6%¹⁷; these findings were published in the Journal of the American Medical Association (JAMA). For the first time, this study proposed a "Chinese approach" to neoadjuvant immunotherapy for triple-negative breast cancer based on the Chinese population, which improved the pathological complete response rate by 12.1%.
The establishment of the world's largest multi-omics cohort for triple-negative breast cancer led to the introduction of the "Fudan Classification," which increased the response rate in treatment-refractory patients from less than 10% to 29.8%.
Specializing in the study of breast cancer metastasis mechanisms and translational research, the researcher has published nearly 350 papers (including over 100 indexed in SCI), served as editor-in-chief for four monographs, and led more than 30 research projects, including those funded by the National Science Fund for Distinguished Young Scholars and the National Basic Research Program (973 Program).